The Global University Venturing Deal Net rounds up the week’s smaller deals and tracks the startups emerging from universities and raising funding.

TechNovum will run from June to October 2019, providing the UTS institute’s faculty with assistance in validating their biomedical propositions for the market.

The biopharmaceutical developer floated at the top of its range and will secure $65.9m from existing backer Merck & Co through a private placement.

Gene engineering tool provider Inscripta has grown its series C round to almost $106m, securing the extra capital from existing backers such as Mérieux Développement.

The radiography image analysis platform developer has completed a series B round that was led by new distribution partner Marubeni.

Unilever Ventures returned to participate in an L Catterton-led series B round that will fund the hair supplement developer's marketing and research and development activities.

Sinopharm Capital helped supply funding to orthopaedic-focused device maker Suzhou and Science Technology Development, with the latter eyeing new products in areas including sports medicine.

The pet food and care provider has formed an open innovation subsidiary, Kinship, which will oversee a $100m strategic investment fund.

Lundbeckfonden Ventures co-led ocular cancer therapy developer Aura's series D round, which also featured Chiesi Ventures.

The Oxford University genetic sequencing spinout is reportedly mulling an IPO that would provide exits to investors including commercialisation firm IP Group.